BLBD vs TM Stock Comparison
TM currently leads BLBD in this stock comparison, with AIQ scores of 71 vs 64. The clearest difference is momentum, while BLBD has the stronger quality profile.
What is the main difference between BLBD and TM?
TM leads the current stock comparison as Toyota Motor Corporation, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Blue Bird Corporation vs Toyota Motor Corporation
TM leads
TM leads by 7 AIQ points, primarily on Momentum and Risk Resilience.
Competitive: 3 of 5 evidence groups support TM, and its current signal state is conflicted.
Blue Bird Corporation
Toyota Motor Corporation
The Algovestiq AIQ Score currently favors TM over BLBD, 71 versus 64 as of Nov 21, 2026. TM's advantage is driven primarily by stronger momentum and risk resilience, while BLBD holds the stronger quality profile. TM also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor TM today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. TM lead: Stable — the AIQ differential has held near 7 points over 30 sessions.
Compare Blue Bird Corporation and Toyota Motor Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BLBD and TM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum53 vs 81TM +28
- Quality76 vs 58BLBD +18
- Risk Resilience63 vs 75TM +12
- Value65 vs 68Even
3 of 5 evidence groups favor TM. TM’s edge is concentrated in momentum and risk resilience; BLBD keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-20, compared against the prior scored session 2026-11-19.
Largest factor move: Momentum +2
New signals
- Downtrend Structure Active — bearish, trend, long horizon
- Price Lost 50-Day MA — bearish, trend, medium horizon
- RSI Midline Rejection — bearish, momentum, short horizon
Largest factor move: Quality -2, not enough on its own to move the overall score.
New signals
- Accumulation Pattern — bullish, volume, medium horizon (2.21x)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.2%)
- MACD Bearish Crossover — bearish, momentum, short horizon
TM's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BLBD and TM both carry a full feed there.
The central trade-off
TM (Toyota Motor Corporation): the stronger current systematic profile, led by momentum and risk resilience.
BLBD (Blue Bird Corporation): the counter-case, on quality, fundamentals — but at materially higher volatility, 47.5% against 38.8%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TMTM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BLBDBLBD on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
TMTM on the Momentum factor, by 28 points.
Lower downside
TMTM on Risk Resilience, by 12 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BLBD | TM | Note |
|---|---|---|---|
| Implied upside to target | — | +10.8% | Level |
| Target dispersion | — | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 8 | 6 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor TM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | TM | 64 vs 71 |
| Fundamentals | BLBD | revenue growth 46.7% vs -1.9%; EPS growth 4.9% vs -49.2%; TTM ROE 28.3% vs 2%; gross margin 20.6% vs 16.9%; operating margin 11.8% vs 7.5% |
| Valuation | Even | Value 65 vs 68 |
| Technicals | TM | Price vs 50-day -1.9% vs 5.7%; vs 200-day -10.8% vs 6.8% |
| Risk Resilience | TM | Risk Resilience 63 vs 75 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BLBD and TM and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 7 points.
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TM.
How the comparison changed
120 daily snapshots · Jun 3 – Nov 20TM lead: Stable — the AIQ differential has held near 7 points over 30 sessions.
- Today
- TM +7
- 64 vs 71
- 7 sessions ago
- TM +9
- 61 vs 70
- 30 sessions ago
- TM +5
- 60 vs 65
- 90 sessions ago
- BLBD +10
- 64 vs 54
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 4 bearish / 2 neutral
Only BLBD
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.02%)
- Downtrend Structure Active — bearish, trend, long horizon
- Price Lost 50-Day MA — bearish, trend, medium horizon
- RSI Midline Rejection — bearish, momentum, short horizon
5 bullish / 3 bearish / 1 neutral, conflicted
Only TM
- Accumulation Pattern — bullish, volume, medium horizon (2.21x)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.2%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
- Volume Surge - Bullish — bullish, volume, short horizon (2.21x)
Both carry 2 more signals that do not separate them: Death Cross Active, ADX Trend Weakening.
TM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.58%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.65%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BLBD closes the Momentum gap — currently 28 points behind, the largest single contributor to TM's edge.
- 2BLBD's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3TM's conflicting signal state resolves bearish — it currently carries 5 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BLBD leads on balance| Metric | BLBD | TM |
|---|---|---|
| Revenue growth (YoY) | 46.7% | -1.9% |
| EPS growth (YoY) | 4.9% | -49.2% |
| Gross margin | 20.6% | 16.9% |
| Operating margin | 11.8% | 7.5% |
| Return on equity (TTM) | 28.3% | 2% |
| Debt to equity | 0.18 | 1.15 |
Performance
Split across windows| Metric | BLBD | TM |
|---|---|---|
| 1 week (5 sessions) | 2.5% | 0.6% |
| 1 month (20 sessions) | 0.2% | 6.4% |
| 3 months (63 sessions) | -8.2% | 6.9% |
| 6 months (126 sessions) | -12.3% | 11.2% |
| Year to date | 20.9% | -1.4% |
| 1 year (252 sessions) | 12.9% | 7.7% |
Technicals
TM has the stronger structure| Metric | BLBD | TM |
|---|---|---|
| RSI (14) | 48.8 | 59.5 |
| ADX (14) | 18 | 22.3 |
| Price vs 50-day | -1.9% | 5.7% |
| Price vs 200-day | -10.8% | 6.8% |
| Volatility (1M, annualized) | 47.5% | 38.8% |
Risk
TM is the more resilient| Metric | BLBD | TM |
|---|---|---|
| Beta | 1.07 | 0.46 |
| Sharpe ratio | 0.39 | 0.25 |
| Sortino ratio | 0.55 | 0.38 |
| Max drawdown | -33.7% | -32.9% |
| Current drawdown | -30.3% | -15% |
| Annualized volatility | 43.4% | 27.7% |
| Value at risk (95%) | -3.7% | -2.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BLBD or TM?
On the Algovestiq AIQ Score, TM is the stronger of the two as of Nov 21, 2026, scoring 71 against BLBD's 64. The edge comes from momentum and risk resilience. BLBD is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BLBD or TM the better buy right now?
TM carries the stronger systematic profile as of Nov 21, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor TM over BLBD?
The composite weights Quality, Value, Momentum and Risk Resilience. TM leads Momentum by 28 points; BLBD leads Quality by 18 points; TM leads Risk Resilience by 12 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BLBD or TM?
Analyst price targets imply not covered upside for BLBD and +10.8% for TM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BLBD or TM?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BLBD or TM?
BLBD on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BLBD or TM?
TM on the Momentum factor, by 28 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BLBD or TM?
TM is the more resilient of the two, so the other name carries the higher downside risk. TM on Risk Resilience, by 12 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BLBD more profitable than TM?
BLBD leads on the comparable margin measures — gross margin 20.6% vs 16.9%; operating margin 11.8% vs 7.5%; ttm roe 28.3% vs 2%.
Is TM's lead over BLBD getting stronger or weaker?
TM lead: Stable — the AIQ differential has held near 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-03 and 2026-11-20. The lead has not changed hands in that window.
What would change the BLBD vs TM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BLBD closes the Momentum gap — currently 28 points behind, the largest single contributor to TM's edge; BLBD's Death Cross Active resolves — a bearish trend rule currently active against it; TM's conflicting signal state resolves bearish — it currently carries 5 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about BLBD and TM?
BLBD: 0 bullish / 4 bearish / 2 neutral. TM: 5 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BLBD is Death Cross Active (bearish, long horizon). On TM it is Death Cross Active (bearish, long horizon).
Compare BLBD and TM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.